Zobrazeno 1 - 10
of 120
pro vyhledávání: '"Cally Roper"'
Autor:
Rosario Martinez-Vega, Wilfred Fon Mbacham, Innocent Ali, Akindeh Nji, Andria Mousa, Khalid B. Beshir, Ana Chopo-Pizarro, Harparkash Kaur, Lucy Okell, Helle Hansson, Emma Filtenborg Hocke, Michael Alifrangis, Roland Gosling, Cally Roper, Colin Sutherland, R. Matthew Chico
Publikováno v:
BMC Infectious Diseases, Vol 24, Iss 1, Pp 1-12 (2024)
Abstract Background The World Health Organization 2022 malaria chemoprevention guidelines recommend providing a full course of antimalarial treatment at pre-defined intervals, regardless of malaria status to prevent illness among children resident in
Externí odkaz:
https://doaj.org/article/010a3991247c4267a89a5e047d7d4a06
Autor:
Gauthier Mesia Kahunu, Sarah Wellmann Thomsen, Louise Wellmann Thomsen, Hypolite Muhindo Mavoko, Patrick Mitashi Mulopo, Emma Filtenborg Hocke, Papy Mandoko Nkoli, Vito Baraka, Daniel T.R. Minja, Andria Mousa, Cally Roper, Destin Mbongi Moke, Dieudonné Mumba Ngoyi, Eric Mukomena Sompwe, Jean Jacques Muyembe Tanfum, Helle Hansson, Michael Alifrangis
Publikováno v:
International Journal of Infectious Diseases, Vol 139, Iss , Pp 41-49 (2024)
Objectives: Partial artemisinin resistance, mediated by Plasmodium falciparum K13 (PfK13) mutations, has been confirmed in certain areas of East Africa that are historically associated with high-level antimalarial resistance. The Democratic Republic
Externí odkaz:
https://doaj.org/article/3b61a5b35d2e4cdeb54a4e4ab9e123b3
Autor:
Andria Mousa, Gina Cuomo-Dannenburg, Hayley A Thompson, R Matthew Chico, Khalid B Beshir, Colin J Sutherland, David Schellenberg, Roly Gosling, Michael Alifrangis, Emma Filtenborg Hocke, Helle Hansson, Ana Chopo-Pizarro, Wilfred F Mbacham, Innocent M Ali, Mike Chaponda, Cally Roper, Lucy C Okell
Publikováno v:
PLoS Medicine, Vol 21, Iss 5, p e1004376 (2024)
BackgroundRecently revised WHO guidelines on malaria chemoprevention have opened the door to more tailored implementation. Countries face choices on whether to replace old drugs, target additional age groups, and adapt delivery schedules according to
Externí odkaz:
https://doaj.org/article/8642cd8c60ea44d795a403882581e2d4
Autor:
Adebanjo J. Adegbola, Omotade A. Ijarotimi, Akaninyene E. Ubom, Bukola A. Adesoji, Olajide E. Babalola, Emma F. Hocke, Helle Hansson, Andria Mousa, Oluseye O. Bolaji, Michael Alifrangis, Cally Roper
Publikováno v:
Malaria Journal, Vol 22, Iss 1, Pp 1-12 (2023)
Abstract Background Malaria is a major public health issue with substantial risks among vulnerable populations. Currently, the World Health Organization (WHO) recommends SP-IPTp in the second and third trimesters. However, the efficacy of SP-IPTp is
Externí odkaz:
https://doaj.org/article/57dcc0a36950423ca53c83c38ae04cef
Autor:
Marit van Lenthe, Renske van der Meulen, Maryvonne Lassovski, Adelaide Ouabo, Edwige Bakula, Colette Badio, Deogratias Cibenda, Lucy Okell, Erwan Piriou, Lynn Grignard, Kjerstin Lanke, Bhargavi Rao, Teun Bousema, Cally Roper
Publikováno v:
Malaria Journal, Vol 18, Iss 1, Pp 1-9 (2019)
Abstract Background Sulfadoxine–pyrimethamine (SP) is a cornerstone of malaria chemoprophylaxis and is considered for programmes in the Democratic Republic of Congo (DRC). However, SP efficacy is threatened by drug resistance, that is conferred by
Externí odkaz:
https://doaj.org/article/43dc475688694ee4afe33ba734387cbc
Publikováno v:
Malaria Journal, Vol 18, Iss 1, Pp 1-10 (2019)
Abstract Parasite resistance against anti-malarial drugs is a major threat to the ongoing malaria control and elimination strategies. This is especially true since resistance to the currently recommended artemisinins and partner drugs has been confir
Externí odkaz:
https://doaj.org/article/0452c31ce74a471090ee9629ce81bd67
Autor:
Ernest Diez Benavente, Monica Campos, Jody Phelan, Debbie Nolder, Jamille G Dombrowski, Claudio R F Marinho, Kanlaya Sriprawat, Aimee R Taylor, James Watson, Cally Roper, Francois Nosten, Colin J Sutherland, Susana Campino, Taane G Clark
Publikováno v:
PLoS Genetics, Vol 16, Iss 2, p e1008576 (2020)
Although Plasmodium vivax parasites are the predominant cause of malaria outside of sub-Saharan Africa, they not always prioritised by elimination programmes. P. vivax is resilient and poses challenges through its ability to re-emerge from dormancy i
Externí odkaz:
https://doaj.org/article/b49bde8315b3485c908068d192269cd1
Publikováno v:
Scientific Reports, Vol 7, Iss 1, Pp 1-15 (2017)
Abstract Intermittent preventive treatment (IPT) with sulphadoxine-pyrimethamine in vulnerable populations reduces malaria morbidity in Africa, but resistance mutations in the parasite dhps gene (combined with dhfr mutations) threaten its efficacy. W
Externí odkaz:
https://doaj.org/article/e25fbf189ec84e18a29a323f18894f1e
Autor:
Ana Rita Gomes, Matt Ravenhall, Ernest Diez Benavente, Arthur Talman, Colin Sutherland, Cally Roper, Taane G. Clark, Susana Campino
Publikováno v:
International Journal for Parasitology: Drugs and Drug Resistance, Vol 7, Iss 2, Pp 174-180 (2017)
Drug resistance is a recurrent problem in the fight against malaria. Genetic and epidemiological surveillance of antimalarial resistant parasite alleles is crucial to guide drug therapies and clinical management. New antimalarial compounds are curren
Externí odkaz:
https://doaj.org/article/95995606817f41fd9a9059ffddf461cb
Autor:
Caroline A. Lynch, Richard Pearce, Hirva Pota, Connie Egwang, Thomas Egwang, Amit Bhasin, Jonathan Cox, Tarekegn A. Abeku, Cally Roper
Publikováno v:
Malaria Journal, Vol 16, Iss 1, Pp 1-9 (2017)
Abstract Background The I164L mutation on the dhfr gene confers high level resistance to sulfadoxine–pyrimethamine (SP) but it is rare in Africa except in a cluster of reports where prevalence >10% in highland areas of southwest Uganda and eastern
Externí odkaz:
https://doaj.org/article/9d86ec8b96b74f7ba0c516579a32104e